Correlation Between Passage Bio and Gracell Biotechnologies

Can any of the company-specific risk be diversified away by investing in both Passage Bio and Gracell Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Gracell Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Passage Bio and Gracell Biotechnologies, you can compare the effects of market volatilities on Passage Bio and Gracell Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Gracell Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Gracell Biotechnologies.

Diversification Opportunities for Passage Bio and Gracell Biotechnologies

0.1

Correlation Coefficient

Passage Bio  Gracell Biotechnologies

Average diversification

The 3 months correlation between Passage and Gracell is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Gracell Biotechnologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gracell Biotechnologies and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Gracell Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gracell Biotechnologies has no effect on the direction of Passage Bio i.e., Passage Bio and Gracell Biotechnologies go up and down completely randomly.

Pair Corralation between Passage Bio and Gracell Biotechnologies

Given the investment horizon of 90 days Passage Bio is expected to under-perform the Gracell Biotechnologies. But the stock apears to be less risky and, when comparing its historical volatility, Passage Bio is 1.05 times less risky than Gracell Biotechnologies. The stock trades about -0.01 of its potential returns per unit of risk. The Gracell Biotechnologies is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  217.00  in Gracell Biotechnologies on September 30, 2024 and sell it today you would earn a total of  185.00  from holding Gracell Biotechnologies or generate 85.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	27.36%
Values	Daily Returns

Passage Bio  vs.  Gracell Biotechnologies

Passage Bio

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Passage Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Passage Bio reported solid returns over the last few months and may actually be approaching a breakup point.

Gracell Biotechnologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Gracell Biotechnologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent fundamental indicators, Gracell Biotechnologies is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Pair Trading with Passage Bio and Gracell Biotechnologies

The main advantage of trading using opposite Passage Bio and Gracell Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Gracell Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gracell Biotechnologies will offset losses from the drop in Gracell Biotechnologies' long position.

The idea behind Passage Bio and Gracell Biotechnologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.